SavedAdd your journal

Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 12

Serum uric acid and uric acid to HDL-cholesterol ratio in coronary artery fistulas

İsa SİNCER
Aslı Kurtar MANSIROĞLU
Yılmaz GÜNEŞ
Yusuf ÇEKİCİ
Pages
2771–2775
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Previous medications were similar between the two groups.Uric acid [5.9 (4.0-8.0) vs. 4.5 (3.5-8.3)) and uric acid / HDL ratio (14 (7-30) vs. 10 (5-32)] were found to be significantly higher inthe fistula group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, we aimed to evaluate retrospectively uric acid and uric acid / high-density lipoprotein (HDL) ratio in patients withcoronary artery fistula who underwent coronary angiography in our cardiology clinic.
📊
Key Findings & Data:In chronic diseases, e.g., chronic kidneydisease, metabolic syndrome, a decrease in HDL is observed, while high uric acid levels have been associated with adverse events.Material and Methods: A total of 111 patients were included in the study, including 46 patients with coronary fistula and 65 controlswith normal coronary arteries.
💡
Conclusion & Impact:Previous medications were similar between the two groups.Uric acid [5.9 (4.0-8.0) vs. 4.5 (3.5-8.3)) and uric acid / HDL ratio (14 (7-30) vs. 10 (5-32)] were found to be significantly higher inthe fistula group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, we aimed to evaluate retrospectively uric acid and uric acid / high-density lipoprotein (HDL) ratio in patients withcoronary artery fistula who underwent coronary angiography in our cardiology clinic. Coronary artery fistulas (CAF) are seen mostoften congenitally but also may be acquired and often encounter an asymptomatic clinic. In chronic diseases, e.g., chronic kidneydisease, metabolic syndrome, a decrease in HDL is observed, while high uric acid levels have been associated with adverse events.Material and Methods: A total of 111 patients were included in the study, including 46 patients with coronary fistula and 65 controlswith normal coronary arteries. Demographic data, laboratory parameters and structural features of the fistula were recorded.Transthoracic echocardiography was performed in all patients.Results: Baseline characteristics were similar between the groups. Previous medications were similar between the two groups.Uric acid [5.9 (4.0-8.0) vs. 4.5 (3.5-8.3)) and uric acid / HDL ratio (14 (7-30) vs. 10 (5-32)] were found to be significantly higher inthe fistula group (p

🔖

Cite This Article

SİNCER, İ., MANSIROĞLU, A. K., GÜNEŞ, Y., ÇEKİCİ, Y. (2022). Serum uric acid and uric acid to HDL-cholesterol ratio in coronary artery fistulas. Annals of Medical Research, Cilt: 26 - Sayı: 12, 2771–2775. https://ajindex.com/articles/447071

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ashraf SS, Shaukat N, Fisher M, et al. Bicoronarypulmonary fistulae with coexistent mitral valve prolapse: a case report and literature review of coronary-pulmonary fistula. European Heart J 1994;15:571-4
  2. Kra SJ. Coronary Arterial Variations in the Normal Heart and in Congenital Heart Disease. Yale J Bio Med1976;49:425
  3. Luo L, Kebede S, Wu S, et al. Coronary artery fistulae. Am J Med Sci 2006;332:79-84
  4. Reidy JF, Anjos RT, Qureshi SA, et al. Transcatheter embolization in the treatment of coronary artery fistulas. J Am College of Cardiol 1991;18:187-92
  5. Somers JM, Verney GI. Coronary cameral fistulae following heart transplantation. Clinical Radiology 1991;44:419-21
  6. Hauser M. Congenital anomalies of the coronary arteries. Heart 2005;9:1240-5
  7. Khan MD, Qureshi SA, Rosenthal E, et al. Neonatal transcatheter occlusion of a large coronary artery fistula with Amplatzer duct occluder. Catheter Cardiovasc Interv 2003;60:282-6
  8. Buccheri D, Chirco PR, Geraci S, et al. Coronary Artery Fistulae: Anatomy, Diagnosis and Management Strategies. Heart, Lung & Circulation 2018;27:940-51
  9. Iribarren C, Folsom AR, Eckfeldt JH, et al. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Annals of Epidemiology 1996;6:331- 40
  10. Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism: Clinical and Experimental 1996;45:699-706
  11. Modan M, Halkin H, Karasik A, et al. Elevated serum uric acid--a facet of hyperinsulinaemia. Diabetologia 1987;30:713-8
  12. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-7
  13. Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. European Heart J 2006;27:1174-81
  14. Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. Jama 2007;298:776-85
  15. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 2001